<VariationArchive RecordType="classified" VariationID="1711158" VariationName="NM_001098.3(ACO2):c.1254dup (p.Gly419fs)" VariationType="Duplication" Accession="VCV001711158" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-10-30" DateCreated="2022-10-22" MostRecentSubmission="2022-10-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1709570" VariationID="1711158">
      <GeneList>
        <Gene Symbol="ACO2" FullName="aconitase 2" GeneID="50" HGNC_ID="HGNC:118" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="41469117" stop="41528974" display_start="41469117" display_stop="41528974" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="41865128" stop="41924992" display_start="41865128" display_stop="41924992" Strand="+" />
          </Location>
          <OMIM>100850</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001098.3(ACO2):c.1254dup (p.Gly419fs)</Name>
      <CanonicalSPDI>NC_000022.11:41522944:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>22q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="41522944" stop="41522945" display_start="41522944" display_stop="41522945" variantLength="1" positionVCF="41522944" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="41918948" stop="41918949" display_start="41918948" display_stop="41918949" variantLength="1" positionVCF="41918948" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>G419fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.41918949dup" Assembly="GRCh37">
            <Expression>NC_000022.10:g.41918949dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.41522945dup" Assembly="GRCh38">
            <Expression>NC_000022.11:g.41522945dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032143.1" sequenceAccession="NG_032143" sequenceVersion="1" change="g.58821dup">
            <Expression>NG_032143.1:g.58821dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001098.3" sequenceAccession="NM_001098" sequenceVersion="3" change="c.1254dup" MANESelect="true">
            <Expression>NM_001098.3:c.1254dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001089.1" sequenceAccession="NP_001089" sequenceVersion="1" change="p.Gly419fs">
            <Expression>NP_001089.1:p.Gly419fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="100850.0021" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001098.3(ACO2):c.1254dup (p.Gly419fs) AND Optic atrophy 9" Accession="RCV002292698" Version="1">
        <ClassifiedConditionList TraitSetID="21086">
          <ClassifiedCondition DB="MedGen" ID="C4225384">Optic atrophy 9</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-10-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-10-22" MostRecentSubmission="2022-10-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">34056600</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="21086" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33082" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Optic atrophy 9</ElementValue>
                <XRef ID="MONDO:0014571" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OPA9</ElementValue>
                <XRef Type="MIM" ID="616289" DB="OMIM" />
              </Symbol>
              <XRef ID="C4225384" DB="MedGen" />
              <XRef ID="MONDO:0014571" DB="MONDO" />
              <XRef Type="MIM" ID="616289" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5051734" SubmissionDate="2022-10-19" DateLastUpdated="2022-10-22" DateCreated="2022-10-22">
        <ClinVarSubmissionID localKey="100850.0021_OPTIC ATROPHY 9, AUTOSOMAL DOMINANT" title="ACO2, 1-BP DUP, 1254A_OPTIC ATROPHY 9, AUTOSOMAL DOMINANT" />
        <ClinVarAccession Accession="SCV002584976" DateUpdated="2022-10-22" DateCreated="2022-10-22" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 21-year-old woman (P15) with isolated optic atrophy (OPA9; 616289), Charif et al. (2021) identified heterozygosity for a de novo 1-bp duplication (c.1254dupA, NM_001098.2), causing a frameshift predicted to result in a premature termination codon (Gly419fsTer10). The variant was not found in her unaffected parents or in the gnomAD database. Western blot showed that ACO2 expression was reduced by 50% in patient cells. Studies in patient fibroblasts showed a 50% decrease in mitochondrial aconitase activity, as well as a significant reduction in the respiration rate with citrate as the sole substrate. With the addition of pyruvate, respiration increased, but to a lower level than wildtype, and the further addition of other Krebs cycle intermediates restored normal respiration, suggesting a possible short-cut adaptation of the tricarboxylic citric acid cycle. In addition, mtDNA abundance was reduced more than 50% in patient cells compared to control cells.</Attribute>
              <Citation>
                <ID Source="PubMed">34056600</ID>
              </Citation>
              <XRef DB="OMIM" ID="616289" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACO2" />
          </GeneList>
          <Name>ACO2, 1-BP DUP, 1254A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 1254A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="100850.0021" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OPTIC ATROPHY 9, AUTOSOMAL DOMINANT</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

